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Abstract
The North American Rheumatoid Arthritis Consortium case-control study collected case
participants across the United States and control participants from New York. More than
500,000 single-nucleotide polymorphisms (SNPs) were genotyped in the sample of 2000 cases and
controls. Careful adjustment for the confounding effect of population stratification must be
conducted when analyzing these data; the variance inflation factor (VIF) without adjustment is 1.44.
In the primary analyses of these data, a clustering algorithm in the program PLINK was used to
reduce the VIF to 1.14, after which genomic control was used to control residual confounding.
Here we use stratification scores to achieve a unified and coherent control for confounding. We
used the first 10 principal components, calculated genome-wide using a set of 81,500 loci that had
been selected to have low pair-wise linkage disequilibrium, as risk factors in a logistic model to
calculate the stratification score. We then divided the data into five strata based on quantiles of the
stratification score. The VIF of these stratified data is 1.04, indicating substantial control of
stratification. However, after control for stratification, we find that there are no significant loci
associated with rheumatoid arthritis outside of the HLA region. In particular, we find no evidence
for association of TRAF1-C5 with rheumatoid arthritis.
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Population stratification occurs when a population is
composed of subpopulations that have varying allele
frequencies. When these subpopulations also have
differing baseline risks for a trait, then population
stratification can lead to spurious allele-trait associations.
To control for confounding by population stratification
in case-control studies, statistical methods have been
developed that use genetic markers to provide informa-
tion on population structure. Among such methods are
genomic control [1,2], structured association [3,4], and
principal components [5,6].
A new statistical approach for controlling for population
stratification in case-control studies was recently pro-
posed by Epstein et al. [7]. This method involves
modeling the odds of disease, given data on substruc-
ture-informative loci. For each participant the stratifica-
tion score, which is that participant’s estimated odds of
disease calculated using his or her substructure-informa-
tive-loci data, is calculated using the disease-odds model.
Next, subjects are assigned to (typically five) strata
defined by quantiles of the stratification score. Finally,
the association between genotypes and the trait is
ascertained using a stratified test. This approach is
similar in spirit to the use of the propensity score to
control for confounding in an observational study [8,9].
Epstein et al. showed that testing using the stratification
score could control for confounding by population
stratification in some situations where other methods
fail [7].
The goal of this study was to assess the effect of
controlling for population stratification in a genome-
wide association study using the stratification score
described above.
Methods
We analyzed the genome-wide association study data
from the North American Rheumatoid Arthritis Con-
sortium (NARAC) provided as Problem 1 for Genetic
Analysis Workshop 16 [10,11]. This dataset is composed
of cases from several sources: families, sib-pairs, sporadic
cases, persons with long time disease, and new onset
cases. Control participants were selected from a popula-
tion-based cancer study in New York, frequency-matched
to case participants for self-reported ethnic origin.
Genotyping was performed with the Illumina Infinium
HumanHap550 (version 1.0) platform (San Diego, CA)
with 545,080 single-nucleotide polymorphisms (SNPs)
for all case participants and 48% of control participants;
33% of controls were genotyped using HumanHap550
version 3.0 and 20% with the HumanHap300 and
HumanHap240S arrays. The multiple sources of case and
control participants in these data argues for careful
examination of the role of population stratification in
any associations found.
We followed the basic quality control procedures out-
lined by Fellay et al. [12], excluding data from SNPs that
hadextensivemissingness(missingness>5%),deviations
from Hardy-Weinberg equilibrium (p-value < 0.001 in
controls), and low minor allele frequency (<1%). After
removing duplicated and contaminated samples, infor-
mation was available for 2058 individuals (868 cases;
1190 controls). Of these, 568 individuals were male and
1490 were female. A total of 501,228 SNPs were used in
subsequent analyses. The average genotyping rate for
subjects was 0.994. PLINK[13] was used for data cleaning
and to calculate both the unstratified and stratified
Mantel-Haenszel allelic association test. p-Values of the
max(T) were computed using both the Bonferroni
method and 10,000 permutation datasets.
We used the stratification score of Epstein et al. to adjust
our analyses for confounding due to population
stratification [7]. The authors focus on adjusting
association tests using a limited number of ancestry-
informative markers and, therefore, partial least squares
(PLS) was used to estimate the stratification score. Here,
no such marker panel was readily available; hence, we
utilized markers from across the genome. Applying PLS
to these data would likely result in substantial overfitting
of the stratification score, leading to a loss of power
[14,15]. In order to appropriately use this genome scale
information, a different approach was needed. Thus we
used a modified principal-component (PC) approach
based on Fellay et al. [12] in place of PLS. Starting with
the 501,228 SNPs that passed our quality control
procedure, this modified PC approach captures the
large-scale genetic variation in the data while minimiz-
ing the influence of a few regions high in linkage
disequilibrium (LD) from dominating the PCs. This is
accomplished by excluding SNPs from the PC analysis
that reside in regions of known high LD and then further
pruning the PC SNP set to minimize the LD between the
remaining SNPs. After this pruning procedure 81,500
SNPs remained. Using the first few PCs, four individuals
(D0009459, D0011466, D0012257, and D0012446)
were found to be significant outliers, suggesting appreci-
able non-European ancestry. These individuals were
excluded from subsequent analyses and, when the PC
analysis was repeated, no further outliers were identified.
The first 10 PCs were then used in a logistic model of
disease to estimate each individual’s stratification score–
their predicted probability of being a case given the
genomic information contained in their PCs. Five strata
were then formed based on the quantiles of the
stratification scores, for use in a stratified association
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presented by this procedure are quite minimal; it took
approximately 30 minutes to generate the principal
components and calculate the stratification score using a
Linux workstation with two dual core 2.39-GHz opteron
processors and 6 GB of RAM.
We measured confounding by population stratification
using the variance inflation factor (VIF), defined as the
median of the observed c
2 test statistics divided by the
expected value of this median under the null hypothesis
of no association of any SNP with rheumatoid arthritis
(RA) [1].
Results
The unstratified analysis has a VIF of 1.44, while the VIF
of the stratified analysis using the method of Epstein
e ta l .w a s1 . 0 3 4 .I nt h i sc o n t e x t ,i ti sw o r t hn o t i n gt h a t
the identity-by-state (IBS) clustering approach to con-
trolling for confounding by population stratification that
is implemented in PLINK, and that was used by Plenge
et al. [11], only attained a VIF of 1.14. For this reason,
Plenge et al. also used genomic control [1,2] to control
the residual confounding.
Aside from SNPs in the HLA region on chromosome 6,
genome-wide we found no SNPs that were significantly
associated with RA at the a = 0.05 level (Figure 1).
Interestingly, rs2900180 and rs3761847 on chromosome 9
in the TRAF1-C5 gene (reported by Plenge et al. [11]) and
rs2476601 on chromosome 1 in the PTPN22 gene
(reported by Begovich et al. [16]), were far from significant
genome-wide (empirical adjusted p =1 ,p = 1 and p =0 . 2 1 ,
respectively). To further investigate, we examined the
f i v e2×3t a b l e sf o rr s 3 7 6 1 8 4 7( F i g u r e2 )a n dn o t e dt h a t
there are only 12 cases in stratum 5. We then pooled strata
4 and 5 and recalculated the VIF to be 1.035. Pooling these
strata did not increase the significance of these three SNPs
(empirical adjusted p =1 ,p =1 ,a n dp = 0.084) and lack of
statistical significance was not due to small strata size. The
top three SNPs ranked by p-values, outside chromosome 6,
were rs2476601 (chromosome 1, empirical p-value = 0.08),
rs6596147 (chromosome 5, empirical p-value = 0.09), and
rs1038848 (chromosome 8, empirical p-value = 0.21).
Conclusion
Differences in recruitment of cases and controls suggest
that control of population stratification is crucial for a
proper analysis of these data. This is confirmed by the
large VIF for the unadjusted analysis. Stratification score
analysis dramatically reduces the VIF, increasing con-
fidence in any associations that are found. Interestingly,
once we controlled for population stratification, we
found no SNPs outside the HLA region on chromosome
6 that were associated with rheumatoid arthritis at the
genome-wide significance level of a = 0.05.
Like all stratified analyses, the stratification score approach
will tend to lose power relative to a pooled (unadjusted)
analysis when there is no confounding. Thus, our failure to
replicate the associations found previously in these data
may result from a loss of power from using the
stratification score approach. However, the large VIF for
these data makes confounding highly likely and, therefore,
a competing explanation is that residual stratification in
the primary analyses led to false associations. Further,
Epstein et al. found that the stratification score approach
had comparable power compared with other methods for
control of population stratification [7]. Finally, we note
that a spurious association may replicate if population
stratification is not fully controlled in each analysis.
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Stratification score tables for association analysis of
SNP rs3761847.
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